ASX Share rice
Tue 04 Aug 2020 - 06:26:am (Sydney)

MEM Share Price

MEMPHASYS LIMITED.MEMPharmaceuticals, Biotechnology & Life Sciences

MEM Company Information

Name:

Memphasys Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

30 Richmond Road Homebush NSW Australia 2140

Phone:

61 2 8415 7300

Exec. Chairman & Interim CEO:

Ms. Alison Mary Coutts B.E., M.B.A., B.E. (Chem), GDipBiotech, MBA

Director of Fin.:

Pablo Neyertz

Chief Operating Officer:

Nick Gorring

Chief Financial Officer of Nusep Ltd:

Mr. Malcolm Coleman

Company Sec.:

Mr. Andrew Metcalfe

Company Overview:

Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, as well as for artificial reproductive techniques for animals; and a polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited is headquartered in Homebush, Australia.

MEM Share Price Information

Shares Issued:

753.97M

Market Capitalisation:

$79.17M

Earnings per Share:

$-0.003

Return On Assets (TTM):

$-0.10

Return On Equity (TTM):

$-0.19

Diluted Earnings Per Share (TTM):

$-0.002

MEM CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-2,123,685

Change To Liabilities:

$1.09M

Total Cashflow From Investing Activities:

$-2,123,685

Net Borrowings:

$1.18M

Net Income:

$-1,044,578

Total Cash From Operating Activities:

$-707,472

Depreciation:

$8.92K

Other Cashflow From Investing Activities:

$2.88K

Change To Account Receivables:

$-620,581

Sale Purchase Of Stock:

$-380,028

Capital Expenditures:

$2.13M

MEM Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-1,044,578

Net Income:

$-1,044,578

Operating Income:

$-1,083,856

Interest Expense:

$47.33K

Total Operating Expenses:

$1.08M

MEM Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$4.66M

Total Liabilities:

$765K

Total Stockholder Equity:

$6.07M

Other Current Liabilities:

$83.04K

Total Assets:

$6.84M

Common Stock:

$43.42M

Other Current Assets:

$1.15M

Retained Earnings:

$-38,803,922

Other Liabilities:

$29.37K

Cash:

$873.57K

Total Current Liabilities:

$732.66K

Short-Term Debt:

$319.37K

Property - Plant & Equipment:

$27.51K

Net Tangible Assets:

$1.42M

Total Current Assets:

$2.15M

Net Receivables:

$1.10M

Short-Term Investments:

$4.68M

Accounts Payable:

$227.09K

Non Currrent Assets (Other):

$4.68M

Short-Term Investments:

$4.68

Non Current Liabilities Total:

$32.34K

MEM Share Price History

MEM News

10 Mar, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, Memphasys...
09 Dec, 2019
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...